MDR-TB crisis - HealthQuill

About Us

Bharti Rana Jayshankar – Founder

She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.

Jay Shankar – Co-founder

He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.

Contact Info

info@healthquill.com

The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in South Africa, which has one of the highest burdens in the world.

Urgent global action needed as multidrug-resistant TB surges among children

HQ Team February 14, 2025: Multidrug-resistant tuberculosis (MDR-TB) among children worldwide is a “silent epidemic” that needs immediate intervention. New data reveals that.

by HealthQuill
February 14, 2025
0 Comments

About Us

Contact Info

Follow Us

Urgent global action needed as multidrug-resistant TB surges among children